文献速递呼吸道感染

由新星诺卡菌引起的伴支气管内受累的肺诺卡菌病

Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis.
PubMed 文献 · Chest · 2024-01-01

本文报告一例由新星诺卡菌引起的伴支气管内受累的罕见肺诺卡菌病。患者为79岁男性,有哮喘史及因肺癌和机化性肺炎行右上肺叶切除术史,因咳嗽和呼吸困难就诊,支气管镜见右侧支气管狭窄伴溃疡性和外生性黏膜病变,经支气管镜痰样本检出新星诺卡菌,经美罗培南2周及口服复方磺胺甲噁唑-甲氧苄啶6个月治疗后黏膜病变完全消失。

要点

  • 支气管镜见黏膜溃疡或外生性病变时应将诺卡菌病纳入鉴别诊断。
  • 经支气管镜痰样本可检出诺卡菌以支持诊断。
  • 该例经美罗培南2周序贯口服复方磺胺甲噁唑-甲氧苄啶6个月后黏膜病变完全消失。

核心结论

  • 由新星诺卡菌引起的伴支气管内受累的肺诺卡菌病为罕见病例,经抗菌治疗后黏膜病变完全消失。

研究设计与样本

  • 单个病例报告,患者为79岁男性,有哮喘史及因肺癌和机化性肺炎行右上肺叶切除术史。

主要发现

  • 患者因咳嗽和呼吸困难就诊,支气管镜见右侧支气管狭窄伴溃疡性和外生性黏膜病变。
  • 经支气管镜采集的痰样本中检出新星诺卡菌。
  • 经美罗培南2周治疗后黏膜病变改善,再经口服复方磺胺甲噁唑-甲氧苄啶6个月后黏膜病变完全消失。

关键数值与推荐

  • 美罗培南疗程为2周,口服复方磺胺甲噁唑-甲氧苄啶疗程为6个月。

临床怎么用

  • 对支气管内黏膜病变的鉴别诊断应考虑诺卡菌病,并通过支气管镜采样送检以明确病原。

局限性

  • 单例病例报告,结论的外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a rare case of pulmonary nocardiosis with endobronchial involvement caused by Nocardia araoensis. A 79-year-old man with a history of asthma and a previous right upper lobectomy for lung cancer and organizing pneumonia presented with cough and dyspnea. He presented with right bronchial stenosis associated with various mucosal lesions, including ulcerative and exophytic lesions. N araoensis was detected in sputum samples collected via bronchoscopy. The mucosal lesions improved after a 2-week course of meropenem. After a further 6 months of oral sulfamethoxazole-trimethoprim treatment, the mucosal lesions completely disappeared. Based on bronchoscopic and pathophysiologic findings, the patient was diagnosed with pulmonary nocardiosis with endobronchial involvement. Nocardiosis should be considered in the differential diagnosis of endobronchial mucosal lesions.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Tajima Y, Tashiro T, Furukawa T, et al. Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis. Chest. 2024. PMID: 38199738. doi:10.1016/j.chest.2023.07.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。